[Sex Differences of the Inflammatory Mediator Level at the Time of Itch Onset in Patients with Chronic Venous Disease]

Yakugaku Zasshi. 2018;138(1):91-96. doi: 10.1248/yakushi.17-00160.
[Article in Japanese]

Abstract

This study investigated the sex differences of the inflammatory mediator level at the time of itch onset in patients with chronic venous disease (CVD). Twenty-seven CVD patients (nineteen women, eight men) and nine healthy controls (five women, four men) participated. CVD-associated itching was observed in both men and women. Before sclerotherapy, both sexes had elevations in several itch-related mediators. Among these, women had significantly higher tryptase, whereas men had significantly higher β-endorphin and adrenocorticotropic hormone. After sclerotherapy, all levels normalized in both sexes. In this study, itching was increased tryptase in women and increased adrenocorticotropic hormone and β-endorphin in men.

Keywords: adrenocorticotropic hormone; beta-endorphin; chronic venous disease; itching; tryptase.

MeSH terms

  • Adrenocorticotropic Hormone / metabolism*
  • Adult
  • Aged
  • Chronic Disease
  • Female
  • Humans
  • Inflammation Mediators / metabolism*
  • Male
  • Middle Aged
  • Pruritus / physiopathology*
  • Sclerotherapy
  • Sex Characteristics*
  • Tryptases / metabolism*
  • Vascular Diseases / metabolism*
  • Vascular Diseases / physiopathology*
  • Vascular Diseases / therapy
  • beta-Endorphin / metabolism*

Substances

  • Inflammation Mediators
  • beta-Endorphin
  • Adrenocorticotropic Hormone
  • Tryptases